Is there a future for the ongoing use of azithromycin for the treatment of Neisseria gonorrhoeae?

F. Y.S. Kong; J. S. Hocking; C. K. Fairley

doi:10.1016/j.cmi.2019.10.015

Is there a future for the ongoing use of azithromycin for the treatment of Neisseria gonorrhoeae?

F. Y.S. Kong, J. S. Hocking, C. K. Fairley

Melbourne Sexual Health Centre

Research output: Contribution to journal › Comment / Debate › Other › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	137-139
Number of pages	3
Journal	Clinical Microbiology and Infection
Volume	26
Issue number	2
DOIs	https://doi.org/10.1016/j.cmi.2019.10.015
Publication status	Published - Feb 2020

Keywords

Azithromycin
Ceftriaxone
Gentamicin
Neisseria gonorrhoeae
Treatment efficacy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmi.2019.10.015

Cite this

@article{b75ecdfb2d7448d3919ced2b8637f572,

title = "Is there a future for the ongoing use of azithromycin for the treatment of Neisseria gonorrhoeae?",

keywords = "Azithromycin, Ceftriaxone, Gentamicin, Neisseria gonorrhoeae, Treatment efficacy",

author = "Kong, {F. Y.S.} and Hocking, {J. S.} and Fairley, {C. K.}",

year = "2020",

month = feb,

doi = "10.1016/j.cmi.2019.10.015",

language = "English",

volume = "26",

pages = "137--139",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",